Dr. Bray Links

Thursday, September 27, 2018

Signs point to growing abuse of gabapentinoids in the U.S. | Internal Medicine News

Three states have now added gabapentin to their list of Schedule V controlled substances: Kentucky in 2017, West Virginia this May, and Tennessee in July.

Ohio, Minnesota, Virginia, and Massachusetts have taken a different tack to controlling dispensing. In those states, all pharmacies, prescribers, and wholesalers must report all dispensing and sales of gabapentin to their prescription monitoring databases.


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.